New York Life Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.54M | Buy |
14,353
+113
| +0.8% | +$59.3K | 0.07% | 244 |
|
|
2025
Q1 | $9.03M | Sell |
14,240
-64
| -0.4% | -$40.6K | 0.09% | 201 |
|
|
2024
Q4 | $10.2M | Buy |
14,304
+55
| +0.4% | +$39.2K | 0.1% | 185 |
|
|
2024
Q3 | $15M | Sell |
14,249
-407
| -3% | -$428K | 0.15% | 141 |
|
|
2024
Q2 | $15.4M | Buy |
14,656
+132
| +0.9% | +$139K | 0.15% | 134 |
|
|
2024
Q1 | $14M | Sell |
14,524
-765
| -5% | -$736K | 0.14% | 141 |
|
|
2023
Q4 | $13.4M | Sell |
15,289
-2,935
| -16% | -$2.58M | 0.14% | 144 |
|
|
2023
Q3 | $15M | Sell |
18,224
-496
| -3% | -$408K | 0.16% | 127 |
|
|
2023
Q2 | $13.5M | Buy |
18,720
+65
| +0.3% | +$46.7K | 0.14% | 143 |
|
|
2023
Q1 | $15.3M | Sell |
18,655
-991
| -5% | -$814K | 0.17% | 131 |
|
|
2022
Q4 | $14.2M | Sell |
19,646
-93
| -0.5% | -$67.1K | 0.16% | 145 |
|
|
2022
Q3 | $13.6M | Sell |
19,739
-319
| -2% | -$220K | 0.16% | 136 |
|
|
2022
Q2 | $11.9M | Buy |
+20,058
| New | +$11.9M | 0.14% | 157 |
|